All entries for: Vertex Pharmaceuticals Inc

February 13, 2026

Vertex Pharmaceuticals Inc

Neutral Outlook

Boston, MA
1,001-5,000 employees

Additionally, in August 2022, the Inflation Reduction Act (“IRA”) was enacted, establishing a Medicare Drug Price Negotiation Program, a Medicare inflationary rebate, and a redesign of the Part D benefit structure.

Disease Area: Chronic Disease, Immune Diseases, Neurological Diseases, Rare Disease
Drug Type: Biologic, Small Molecule
Scroll to Top